The Naica™ system, Stilla Technologies' innovative digital PCR solution, combined with a Covid-19 detection kit, is able to quickly, accurately and reliably identify the SARS-CoV-2 virus, which is responsible for Covid-19, as well as measure its viral load. At the moment, the Naica system is mainly being used for research, and the company plans on expanding its use to diagnosis. Paris -- Stilla Technologies, a leading French provider of pioneering solutions for high-precision genetic analyses, just announced that its [...]

Boston, MA: LabMinds, Inc., a next-generation robotics company focused on solution preparation, announces that Jeff Caputo has been named as President and Chief Executive Officer and a Member of the Board of Directors. Jeff brings over 18 years of experience in the life science industry in a variety of commercial, investing and operating roles, most [...]

Merged Companies to Operate as Synergistic Divisions. New Corporate Identity Focuses on Optimizing Bioavailability, Absorption, Quality and Performance of Human, Animal and Agricultural Products SOUTH EASTON, Mass. -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to [...]

ANN ARBOR, Mich. -- Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), announced the release of its Swift Amplicon SARS-CoV-2 Research Panel. Targeting the full viral genome in a single reaction with a rapid 2-hour workflow, Swift's assay meets research and surveillance needs for standard samples [...]

HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of anti-certolizumab pegol inhibitory antibodies to support the development of assays for therapeutic drug monitoring of tumor necrosis factor (TNF) alpha inhibitors. By extending its offering to include anti-certolizumab [...]

Göttingen New, patent pending optical module incorporates long wavelength NIR fluorescence to reduce phototoxicity in long term live-cell experiments Up to five different fluorescence channels allow researchers to explore new applications, such as metabolism, with addition of new live-cell ATP and MMP assays More plex, up to three fluorescence channels and HD phase in a [...]

Collaboration focuses on developing multiplexed gene editing approaches using single-cell nano-manipulation technology that maintains cell viability and fitness WYSS INSTITUTE FOR BIOLOGICALLY INSPIRED ENGINEERING AT HARVARD IMAGE: HARVARD'S WYSS INSTITUTE COLLABORATES WITH CYTOSURGE TO ENABLE MULTIPLEXED GENOME EDITING. UP UNTIL NOW, THE DELIVERY OF GENOME EDITING AGENTS LIKE CRISPR-CAS9 (LAVENDER) USING DELIVERY VECTORS (PINK), AND ALLOWING [...]

London, UK –  The UK genomic tools developer, RevoluGen Ltd., has appointed Sir John Chisholm as non-executive Chairman. Sir John was most recently Executive Chairman of Genomics England in which role he oversaw the world leading 100,000 Genome Project, which led to the UK being the first country to introduce Genomic Medicine into its health system. [...]

High-speed analysis enables live process and safety control, energy efficiency and yield improvements, as well as air emissions reductions Yokogawa Corporation of America has released the TDLS8100 probe-type Tunable Diode Laser Spectrometer (TDLS). Industrial process heating operations – fired heaters, boilers and furnaces – account for approximately 70% of the manufacturing sector’s process energy consumption [...]

NEW YORK--Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced the appointments of Jeffrey A. Chodakewitz, M.D., and Gary Ginsberg to its Board of Directors. Dr. Chodakewitz is a veteran in the biopharmaceutical industry who previously held leadership roles at Vertex Pharmaceuticals and Merck & [...]